| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arteriosclerosis and Thrombosis, Vol 14, 1892-1899, Copyright © 1994 by American Heart Association
ARTICLES |
E Maggi, R Chiesa, G Melissano, R Castellano, D Astore, A Grossi, G Finardi and G Bellomo
Department of Internal Medicine, University of Pavia, Italy.
Among the various risk factors involved in the development and progression of carotid atherosclerosis, the oxidation of LDL has been proposed to play a relevant role. LDL oxidation has been investigated in 94 patients with severe carotid atherosclerosis undergoing elective carotid artery endarterectomy and in 42 matched control subjects. LDL oxidation was evaluated in all patients as (1) the susceptibility to in vitro oxidation, (2) vitamin E concentration and its efficiency in LDL, and (3) the presence of autoantibodies against oxidatively modified lipoprotein to monitor the occurrence of the oxidative processes taking place in vivo. No difference was detected between control subjects and patients concerning vitamin E concentration and the kinetics of conjugated diene formation in isolated LDL exposed to CuSO4. However, vitamin E efficiency was lower (9.6 +/- 4.2 versus 30.2 +/- 7.6 min/nmol vitamin E) and the duration of the vitamin E-independent lag phase was longer (105.5 +/- 16.5 versus 58 +/- 11.8 minutes) in the patient group. Autoantibodies against oxidatively modified lipoproteins were measured with an ELISA method using native LDL, Cu(2+)-oxidized LDL (oxLDL), or malondialdehyde-derivatized LDL (MDA-LDL) as antigens. To monitor cross-reactivity of the antibodies detected with other oxidatively modified proteins, human serum albumin (HSA) and MDA- derivatized HSA (MDA-HSA) were also employed. The antibody titer was calculated as the ratio of antibodies against modified versus native proteins.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
S. G. Tsouli, D. N. Kiortsis, V. Xydis, M. I. Argyropoulou, M. Elisaf, and A. D. Tselepis Antibodies Against Various Forms of Mildly Oxidized Low-Density Lipoprotein Are Not Associated With Carotid Intima-Media Thickness in Patients With Primary Hyperlipidemia Angiology, October 1, 2006; 57(5): 615 - 622. [Abstract] [PDF] |
||||
![]() |
F. Piarulli, A. Lapolla, G. Sartore, C. Rossetti, G. Bax, M. Noale, N. Minicuci, C. Fiore, L. Marchioro, E. Manzato, et al. Autoantibodies Against Oxidized LDLs and Atherosclerosis in Type 2 Diabetes Diabetes Care, March 1, 2005; 28(3): 653 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? Circulation, October 26, 2004; 110(17): 2552 - 2558. [Full Text] [PDF] |
||||
![]() |
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing J. Physiol., April 1, 2004; 556(1): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Virella and M. F. Lopes-Virella Lipoprotein Autoantibodies: Measurement and Significance Clin. Vaccine Immunol., July 1, 2003; 10(4): 499 - 505. [Full Text] [PDF] |
||||
![]() |
G. N. Fredrikson, B. Hedblad, G. Berglund, R. Alm, M. Ares, B. Cercek, K.-Y. Chyu, P. K. Shah, and J. Nilsson Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 872 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayashi, M. Kishi, T. Atsumi, M. L. Bertolaccini, H. Makino, N. Sakairi, I. Yamamoto, T. Yasuda, M. A. Khamashta, G. R. V. Hughes, et al. Circulating oxidized LDL forms complexes with {beta}2-glycoprotein I: implication as an atherogenic autoantigen J. Lipid Res., April 1, 2003; 44(4): 716 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Liu, K. Ylitalo, I. Nuotio, R. Salonen, J. T. Salonen, and M.-R. Taskinen Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families Stroke, May 1, 2002; 33(5): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Sherer and Y Shoenfeld Atherosclerosis Ann Rheum Dis, February 1, 2002; 61(2): 97 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson, M.P.S. Ares, M. Lindholm, G.N. Fredriksonl, and S. Jovinge Inflammation and cholesterol Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A18 - A25. [Abstract] [PDF] |
||||
![]() |
P. Rubba, S. Panico, M. G. Bond, G. Covetti, E. Celentano, A. Iannuzzi, R. Galasso, M. A. Belisario, A. Pastinese, L. Sacchetti, et al. Site-Specific Atherosclerotic Plaques in the Carotid Arteries of Middle-Aged Women From Southern Italy: Associations With Traditional Risk Factors and Oxidation Markers Stroke, September 1, 2001; 32(9): 1953 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trevisan, R. Browne, M. Ram, P. Muti, J. Freudenheim, A. M. Carosella, and D. Armstrong Correlates of Markers of Oxidative Status in the General Population Am. J. Epidemiol., August 15, 2001; 154(4): 348 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Berco and B. R. Bhavnani Differential Neuroprotective Effects of Equine Estrogens Against Oxidized Low Density Lipoprotein--Induced Neuronal Cell Death Reproductive Sciences, July 1, 2001; 8(4): 245 - 254. [Abstract] [PDF] |
||||
![]() |
M. Haidari, E. Javadi, M. Kadkhodaee, and A. Sanati Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease Clin. Chem., July 1, 2001; 47(7): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D O'Reilly, A. I Mallet, G. T McAnlis, I. S Young, B. Halliwell, T. A. Sanders, and H. Wiseman Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans Am. J. Clinical Nutrition, June 1, 2001; 73(6): 1040 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pratico, R. K. Tangirala, S. Horkko, J. L. Witztum, W. Palinski, and G. A. FitzGerald Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2{alpha}-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E Blood, January 15, 2001; 97(2): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wu, C. Lemne, U. de Faire, and J. Frostegard Antibodies to Lysophosphatidylcholine Are Decreased in Borderline Hypertension Hypertension, January 1, 2001; 37(1): 154 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, A. J. Fleming, S. Wu, G. Virella, and M. F. Lopes-Virella Fc-{{gamma}} Receptor Cross-Linking by Immune Complexes Induces Matrix Metalloproteinase-1 in U937 Cells via Mitogen-Activated Protein Kinase Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2533 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukumoto, T. Shoji, M. Emoto, T. Kawagishi, Y. Okuno, and Y. Nishizawa Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Deguchi, J. A. Fernandez, T. M. Hackeng, C. L. Banka, and J. H. Griffin Cardiolipin is a normal component of human plasma lipoproteins PNAS, February 15, 2000; 97(4): 1743 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lepage, F. Nigon, D. Bonnefont-Rousselot, U. Assogba, S. Goulinet, L. Chancharme, J. Delattre, E. Bruckert, and M. J. Chapman Oxidizability of Atherogenic Low-Density Lipoprotein Subspecies in Severe Familial Hypercholesterolemia: Impact of Long-Term Low-Density Lipoprotein Apheresis Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 87 - 103. [Abstract] [PDF] |
||||
![]() |
A. T. Erkkila, O. Narvanen, S. Lehto, M. I. J. Uusitupa, and S. Yla-Herttuala Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 204 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, A. Jaffa, S. Koskinen, A. Takei, and M. F. Lopes-Virella Oxidized LDL-Containing Immune Complexes Induce Fc Gamma Receptor I–Mediated Mitogen-Activated Protein Kinase Activation in THP-1 Macrophages Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1600 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Craig, M. W. Rawstron, C. A. Rundell, E. Robinson, S. E. Poulin, L. M. Neveux, P. M. Nishina, and L. M. Keilson Relationship Between Lipoprotein- and Oxidation-Related Variables and Atheroma Lipid Composition in Subjects Undergoing Coronary Artery Bypass Graft Surgery Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1512 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Islam, B. Gutin, F. Treiber, G. Hobbs, I. Kamboh, and M. Lopes-Virella Association of Apolipoprotein A Phenotypes and Oxidized Low-Density Lipoprotein Immune Complexes in Children Arch Pediatr Adolesc Med, January 1, 1999; 153(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wu, U. de Faire, C. Lemne, J. L. Witztum, and J. Frostegard Autoantibodies to OxLDL Are Decreased in Individuals With Borderline Hypertension Hypertension, January 1, 1999; 33(1): 53 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Reilly, D. Pratico, N. Delanty, G. DiMinno, E. Tremoli, D. Rader, S. Kapoor, J. Rokach, J. Lawson, and G. A. FitzGerald Increased Formation of Distinct F2 Isoprostanes in Hypercholesterolemia Circulation, December 22, 1998; 98(25): 2822 - 2828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Freigang, S. Horkko, E. Miller, J. L. Witztum, and W. Palinski Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodies to Oxidative Neoepitopes Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1972 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. G. Princen, W. van Duyvenvoorde, R. Buytenhek, C. Blonk, L. B. M. Tijburg, J. A. E. Langius, A. E. Meinders, and H. Pijl No Effect of Consumption of Green and Black Tea on Plasma Lipid and Antioxidant Levels and on LDL Oxidation in Smokers Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 833 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiechl, J. Willeit, G. Egger, W. Poewe, F. Oberhollenzer, and f. t. B. S. Group Body Iron Stores and the Risk of Carotid Atherosclerosis : Prospective Results From the Bruneck Study Circulation, November 18, 1997; 96(10): 3300 - 3307. [Abstract] [Full Text] |
||||
![]() |
P. Reaven, S. Merat, F. Casanada, M. Sutphin, and W. Palinski Effect of Streptozotocin-Induced Hyperglycemia on Lipid Profiles, Formation of Advanced Glycation Endproducts in Lesions, and Extent of Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2250 - 2256. [Abstract] [Full Text] |
||||
![]() |
C.-H. Chen, J. Cartwright Jr, Z. Li, S. Lou, H. H. Nguyen, A. M. Gotto Jr, and P. D. Henry Inhibitory Effects of Hypercholesterolemia and Ox-LDL on Angiogenesis-like Endothelial Growth in Rabbit Aortic Explants : Essential Role of Basic Fibroblast Growth Factor Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1303 - 1312. [Abstract] [Full Text] |
||||
![]() |
D. Halevy, J. Thiery, D. Nagel, S. Arnold, E. Erdmann, B. Hofling, P. Cremer, and D. Seidel Increased Oxidation of LDL in Patients With Coronary Artery Disease Is Independent From Dietary Vitamins E and C Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1432 - 1437. [Abstract] [Full Text] |
||||
![]() |
C. Iribarren, A. R. Folsom, D. R. Jacobs Jr, M. D. Gross, J. D. Belcher, and J. H. Eckfeldt Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies Against MDA-LDL With Carotid Atherosclerosis: A Case-Control Study Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1171 - 1177. [Abstract] [Full Text] |
||||
![]() |
A. D. Watson, N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo J. Biol. Chem., May 23, 1997; 272(21): 13597 - 13607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Salonen, K. Nyyssonen, R. Salonen, E. Porkkala-Sarataho, T.-P. Tuomainen, U. Diczfalusy, and I. Bjorkhem Lipoprotein Oxidation and Progression of Carotid Atherosclerosis Circulation, February 18, 1997; 95(4): 840 - 845. [Abstract] [Full Text] |
||||
![]() |
Y. B. de Rijke*, S. J.H. Bredie*, P. N.M. Demacker, J. M. Vogelaar, H. L.M. Hak-Lemmers, and A. F.H. Stalenhoef The Redox Status of Coenzyme Q10 in Total LDL as an Indicator of In Vivo Oxidative Modification: Studies on Subjects With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 127 - 133. [Abstract] [Full Text] |
||||
![]() |
M. Seccia, E. Albano, E. Maggi, and G. Bellomo Circulating Autoantibodies Recognizing Peroxidase-Oxidized Low Density Lipoprotein: Evidence for New Antigenic Epitopes Formed In Vivo Independently From Lipid Peroxidation Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 134 - 140. [Abstract] [Full Text] |
||||
![]() |
M. I.J. Uusitupa, L. Niskanen, J. Luoma, P. Vilja, M. Mercuri, R. Rauramaa, and S. Yla-Herttuala Autoantibodies Against Oxidized LDL Do Not Predict Atherosclerotic Vascular Disease in Non–Insulin-Dependent Diabetes Mellitus Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1236 - 1242. [Abstract] [Full Text] |
||||
![]() |
S. Ameli, A. Hultgardh-Nilsson, J. Regnstrom, F. Calara, J. Yano, B. Cercek, P. K. Shah, and J. Nilsson Effect of Immunization With Homologous LDL and Oxidized LDL on Early Atherosclerosis in Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1074 - 1079. [Abstract] [Full Text] |
||||
![]() |
T. Heitzer, S. Yla-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia : Role of Oxidized LDL Circulation, April 1, 1996; 93(7): 1346 - 1353. [Abstract] [Full Text] |
||||
![]() |
C. M. Beard, R. J. Barnard, D. C. Robbins, J. M. Ordovas, and E. J. Schaefer Effects of Diet and Exercise on Qualitative and Quantitative Measures of LDL and Its Susceptibility to Oxidation Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 201 - 207. [Abstract] [Full Text] |
||||
![]() |
M. Mironova, G. Virella, and M. F. Lopes-Virella Isolation and Characterization of Human Antioxidized LDL Autoantibodies Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 222 - 229. [Abstract] [Full Text] |
||||
![]() |
B. J. Auerbach, C. L. Bisgaier, J. Wölle, and U. Saxena Oxidation of Low Density Lipoproteins Greatly Enhances Their Association with Lipoprotein Lipase Anchored to Endothelial Cell Matrix J. Biol. Chem., January 19, 1996; 271(3): 1329 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Palinski, R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1569 - 1576. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |